GHK-Cu and the copper-peptide research field

Loren Pickart isolated GHK from human plasma in 1973 while looking for a factor that explained why hepatocytes from older donors recovered like younger cells when cultured in young plasma. The active fraction turned out to be a tripeptide — glycyl-L-histidyl-L-lysine — present at higher concentrations in young plasma than old. Pickart's later work showed the peptide's biological activity required copper coordination.

By the late 1980s, the GHK-Cu complex was being studied in dermal-matrix and wound-healing contexts. The 1990s and 2000s added transcriptomic work — gene-expression studies showing GHK influencing clusters of genes well beyond the immediate copper-binding biology.

Free GHK and GHK-Cu are not equivalent in cell-culture work. The peptide has a very high affinity for Cu(II), and the copper complex is the form that interacts with copper-dependent enzymes, intracellular transport proteins, and oxidative-stress pathways.

Practical consequence: when reading or designing GHK experiments, distinguish 'GHK' (apo-peptide) from 'GHK-Cu' (copper-complexed). Many older studies used 'GHK' as shorthand for the complex, since serum contains enough copper to form it in situ — but in serum-free culture the distinction matters.

Dermal matrix: increased collagen I, III, and elastin synthesis in fibroblast cultures and skin explants. GAG and proteoglycan synthesis up-regulated.

MMP modulation: differential effects on matrix metalloproteinases — MMP-2 induction in some contexts, MMP-1 suppression in others. The 'remodelling' effect attributed to GHK in cosmetic literature draws from this balance.

Transcriptomic profile: published gene-expression studies report GHK-driven shifts in DNA repair clusters (excision repair, base-excision repair), antioxidant response (Nrf2-adjacent), and anti-inflammatory mediators. The breadth of this transcriptomic footprint is part of why GHK keeps reappearing in 'longevity peptide' discourse.

Wound healing: improved closure rates in rodent models of acute and chronic wounds; granulation tissue formation supported in diabetic-wound models.

GHK-Cu is supplied as a lyophilised peptide that reconstitutes to a characteristic deep-blue solution — the colour is a visual readout that the copper coordination is intact. A pale or colourless solution suggests the copper has dissociated or was not present in the source material.

Working concentrations in published in-vitro work range from 10 nM to 10 μM depending on the assay. Skin-explant work tends to sit higher (μM range) than fibroblast monolayer work (low-nM to mid-nM).

Reconstituted GHK-Cu is sensitive to long-term oxidation; aliquoting and freezing extends working life. Avoid reducing agents in the buffer system — they can strip the copper.